Question 1

Does Citadel Advisors own VYGR stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Citadel Advisors holds 784,067 shares of VYGR (Voyager Therapeutics), worth $2.7M.

Question 2

How many shares of VYGR does Citadel Advisors own?

Accepted Answer

As of its Q2 2026 13F, Citadel Advisors holds 784,067 shares of VYGR (Voyager Therapeutics).

Question 3

What is Citadel Advisors' VYGR position worth?

Accepted Answer

As of its Q2 2026 13F, Citadel Advisors' VYGR position is worth $2.7M.

Question 4

Is Citadel Advisors buying or selling VYGR?

Accepted Answer

In Q2 2026, Citadel Advisors increased its VYGR position by 419,403 shares (+115.0%).

Question 5

When did Citadel Advisors first buy VYGR?

Accepted Answer

Citadel Advisors already held VYGR in its Q4 2018 13F, the earliest on record, and has listed it in 29 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	784,067	+115.0%	$2.7M	0.0%	$3.50	42
2026-Q1	Decreased	364,664	-34.5%	$1.4M	0.0%	$3.86	0
2025-Q4	Increased	556,646	+39.8%	$2.2M	0.0%	$3.93	34
2025-Q3	Increased	398,226	+104.6%	$1.9M	0.0%	$4.67	42
2025-Q2	Increased	194,653	+175.7%	$605,371	0.0%	$3.11	39
2025-Q1	Increased	70,609	+1884.5%	$238,658	0.0%	$3.38	25
2024-Q4	Decreased	3,558	-98.6%	$20,174	0.0%	$5.67	0
2024-Q3	Increased	247,636	+114.2%	$1.4M	0.0%	$5.85	41